Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. iTS platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers.
Company profile
Ticker
PRVA
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
PH Group Parent Corp.
SEC CIK
Corporate docs
Subsidiaries
Bass Privia Management Company • Complete MD Solutions, LLC • Patient Health Advocacy Solutions, LLC • PH Group Holdings Corp. • PMG POL, LLC • PQN-Central Texas, LLC • PQN-Georgia, LLC • Privia Care Center, LLC • Privia Care Partners Georgia, LLC • Privia DC Metro Management Company, LLC ...
PRVA stock data
Analyst ratings and price targets
Current price
Average target
$35.00
Low target
$28.00
High target
$43.00
Stifel
Initiated
$28.00
UBS
Initiated
$30.00
Canaccord Genuity
Maintains
$43.00
SVB Leerink
Maintains
$39.00
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
9 Jan 23
8-K
Entry into a Material Definitive Agreement
21 Nov 22
424B7
Prospectus with selling stockholder info
17 Nov 22
424B7
Prospectus with selling stockholder info
15 Nov 22
S-3ASR
Automatic shelf registration
15 Nov 22
8-K
Privia Health Announces Change to its Board of Directors
15 Nov 22
8-K
Amendments to Articles of Incorporation or Bylaws
10 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Privia Health Reports Third Quarter 2022 Financial Results
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Transcripts
PRVA
Earnings call transcript
2022 Q3
13 Nov 22
PRVA
Earnings call transcript
2022 Q2
11 Aug 22
PRVA
Earnings call transcript
2022 Q1
14 May 22
PRVA
Earnings call transcript
2021 Q4
25 Mar 22
PRVA
Earnings call transcript
2021 Q3
8 Nov 21
PRVA
Earnings call transcript
2021 Q2
9 Aug 21
PRVA
Earnings call transcript
2021 Q1
28 May 21
Latest ownership filings
4
William M Sullivan
24 Jan 23
4
William M Sullivan
17 Jan 23
4
Thomas Bartrum
17 Jan 23
4
William M Sullivan
10 Jan 23
4
William M Sullivan
27 Dec 22
4/A
David Mountcastle
20 Dec 22
3/A
David Mountcastle
20 Dec 22
4
William M Sullivan
15 Dec 22
4
William M Sullivan
12 Dec 22
4
William M Sullivan
29 Nov 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 316.90 mm | 316.90 mm | 316.90 mm | 316.90 mm | 316.90 mm | 316.90 mm |
Cash burn (monthly) | (no burn) | 3.77 mm | 1.52 mm | 3.48 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 14.69 mm | 5.94 mm | 13.58 mm | n/a | n/a |
Cash remaining | n/a | 302.21 mm | 310.95 mm | 303.32 mm | n/a | n/a |
Runway (months of cash) | n/a | 80.2 | 203.9 | 87.1 | n/a | n/a |
Institutional ownership, Q3 2022
89.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 203 |
Opened positions | 70 |
Closed positions | 20 |
Increased positions | 55 |
Reduced positions | 55 |
13F shares | Current |
---|---|
Total value | 3.25 bn |
Total shares | 101.70 mm |
Total puts | 134.50 k |
Total calls | 303.60 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
GS Goldman Sachs | 28.01 mm | $954.10 mm |
Pamplona Capital Partners III | 20.02 mm | $517.91 mm |
William M Sullivan | 6.35 mm | $164.25 mm |
Vanguard | 4.82 mm | $164.33 mm |
BK Bank Of New York Mellon | 3.65 mm | $124.44 mm |
BLK Blackrock | 3.28 mm | $111.85 mm |
T. Rowe Price Investment Management | 2.77 mm | $94.51 mm |
Riverbridge Partners | 1.98 mm | $67.51 mm |
FMR | 1.44 mm | $49.17 mm |
MS Morgan Stanley | 1.41 mm | $48.10 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Jan 23 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 25.36 | 18,153 | 460.36 k | 5,808,777 |
12 Jan 23 | Thomas Bartrum | Common Stock, $0.01 par value per share | Sell | Dispose S | No | Yes | 25.39 | 15,000 | 380.85 k | 91,355 |
12 Jan 23 | Thomas Bartrum | Common Stock, $0.01 par value per share | Option exercise | Acquire M | No | No | 2 | 15,000 | 30.00 k | 106,355 |
12 Jan 23 | Thomas Bartrum | Stock Option (Right to Purchase) Common Stock | Option exercise | Dispose M | No | No | 2 | 15,000 | 30.00 k | 191,228 |
12 Jan 23 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 25.02 | 6,038 | 151.07 k | 5,826,930 |
6 Jan 23 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 21.24 | 12,115 | 257.32 k | 5,832,968 |
23 Dec 22 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 23.39 | 12,115 | 283.37 k | 5,845,083 |
News
4 Analysts Have This to Say About Privia Health Group
9 Dec 22
Stifel Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $28
9 Dec 22
UBS Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $30
8 Dec 22
Reported Late Monday, NeoGenomics Announces Jeffrey S. Sherman Will Join The Company As Chief Financial Officer Effective December 7, Succeeding William Bonello Who Will Remain With The Company To Provide Transition And Onboarding Support For A Period Of Time
6 Dec 22
Target, Holley, Ferroglobe And Other Big Losers From Wednesday
17 Nov 22
Press releases
Privia Health Launches Two New Accountable Care Organizations
17 Jan 23
Privia Health Enters Delaware with Beebe Healthcare; Launches Ninth ACO
17 Jan 23
NeoGenomics Announces Chief Financial Officer Transition
5 Dec 22
Privia Health Announces Pricing of Secondary Offering
16 Nov 22
Privia Health Announces Secondary Offering
15 Nov 22